Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history
Congo on Thursday began vaccinating people against Ebola as health authorities work to slow the fastest-growing outbreak of the disease in history.
Aug 28, 2026
0
27
MeSH tree: E05.337.300
Congo on Thursday began vaccinating people against Ebola as health authorities work to slow the fastest-growing outbreak of the disease in history.
Aug 28, 2026
0
27
U.S. Food and Drug Administration (FDA) advisory committees play a key role in evaluating the efficacy and safety of new drugs. They include open public hearing sessions, whereby patients, clinicians, and advocates share ...
Nov 24, 2025
0
12
Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in American public health.
May 1, 2025
0
13
New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and smaller, emerging biotechnology companies ...
Jul 26, 2024
0
71
Developing new drugs is paramount in discovering innovative treatments and preventing diseases. This is vital not only for advancing medicine but also for the overall health and well-being of humanity. Yet, even when drugs ...
Sep 8, 2023
0
55
The National Institutes of Health (NIH) spent $187 billion for basic or applied research related to 354 of the 356 drugs approved by the FDA from 2010 to 2019, according to a new study from Bentley University's Center for ...
Apr 28, 2023
0
80
Hundreds of pharmaceutical executives on Monday condemned a US judicial ruling outlawing a leading abortion pill, saying it threatens the development of needed medications in the United States.
Apr 10, 2023
0
39
Clinical trials are critical to the development and approval of medical treatments, whether those are drugs, vaccines or medical devices. It is challenging to recruit certain people for clinical trials for different reasons, ...
Dec 1, 2022
0
44
A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Sep 30, 2022
0
91